HK1036069A1 - Nucleosides with anti-hepatitis b virus activity - Google Patents
Nucleosides with anti-hepatitis b virus activityInfo
- Publication number
- HK1036069A1 HK1036069A1 HK01106816A HK01106816A HK1036069A1 HK 1036069 A1 HK1036069 A1 HK 1036069A1 HK 01106816 A HK01106816 A HK 01106816A HK 01106816 A HK01106816 A HK 01106816A HK 1036069 A1 HK1036069 A1 HK 1036069A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- hepatitis
- nucleosides
- acyl
- virus activity
- virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10711698P | 1998-11-05 | 1998-11-05 | |
US11565399P | 1999-01-13 | 1999-01-13 | |
PCT/US1999/026157 WO2000026225A2 (en) | 1998-11-05 | 1999-11-05 | Nucleosides with anti-hepatitis b virus activity |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1036069A1 true HK1036069A1 (en) | 2001-12-21 |
Family
ID=26804401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01106816A HK1036069A1 (en) | 1998-11-05 | 2001-09-27 | Nucleosides with anti-hepatitis b virus activity |
Country Status (14)
Country | Link |
---|---|
US (1) | US6458773B1 (ja) |
EP (1) | EP1124839B1 (ja) |
JP (2) | JP2002528554A (ja) |
KR (1) | KR100618028B1 (ja) |
CN (1) | CN1216893C (ja) |
AT (1) | ATE315574T1 (ja) |
AU (1) | AU774720B2 (ja) |
BR (1) | BR9915555A (ja) |
CA (1) | CA2348470C (ja) |
DE (1) | DE69929460D1 (ja) |
HK (1) | HK1036069A1 (ja) |
IL (2) | IL142983A0 (ja) |
MX (1) | MXPA01004504A (ja) |
WO (1) | WO2000026225A2 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100954390B1 (ko) * | 1998-02-25 | 2010-04-26 | 에모리 유니버시티 | 2'-플루오로뉴클레오사이드 |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
NZ547204A (en) * | 2000-05-26 | 2008-01-31 | Idenix Cayman Ltd | Methods and compositions for treating flaviviruses and pestiviruses |
WO2002094844A2 (en) * | 2001-05-18 | 2002-11-28 | Rakesh Kumar | Antiviral nucleosides |
US7608600B2 (en) * | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
JP2005533824A (ja) | 2002-06-28 | 2005-11-10 | イデニクス(ケイマン)リミテツド | フラビウイルス科感染の治療のための2’−c−メチル−3’−o−l−バリンエステルリボフラノシルシチジン |
NZ537662A (en) | 2002-06-28 | 2007-10-26 | Idenix Cayman Ltd | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
US20040067877A1 (en) | 2002-08-01 | 2004-04-08 | Schinazi Raymond F. | 2', 3'-Dideoxynucleoside analogues for the treatment or prevention of Flaviviridae infections |
KR101026294B1 (ko) * | 2002-10-31 | 2011-03-31 | 메타베이시스 테라퓨틱스, 인크. | 1,3-프로판-1-아릴 디올의 신규 시클릭 포스페이트디에스테르 및 프로드럭 제조에서의 이들의 용도 |
WO2004046331A2 (en) | 2002-11-15 | 2004-06-03 | Idenix (Cayman) Limited | 2’-branched nucleosides and flaviviridae mutation |
WO2004052899A2 (en) | 2002-12-12 | 2004-06-24 | Idenix (Cayman) Limited | Process for the production of 2'-branched nucleosides |
US7781576B2 (en) | 2005-12-23 | 2010-08-24 | Idenix Pharmaceuticals, Inc. | Process for preparing a synthetic intermediate for preparation of branched nucleosides |
WO2015123352A1 (en) | 2014-02-13 | 2015-08-20 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
CN106687118A (zh) | 2014-07-02 | 2017-05-17 | 配体药物公司 | 前药化合物及其用途 |
CN111788196A (zh) | 2018-01-09 | 2020-10-16 | 配体药物公司 | 缩醛化合物及其治疗用途 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4841039A (en) | 1986-05-01 | 1989-06-20 | Emory University | 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents |
US4681933A (en) | 1986-05-01 | 1987-07-21 | University Of Georgia Research Foundation, Inc. | 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents |
US5084445A (en) | 1986-05-01 | 1992-01-28 | University Of Georgia Research Foundation, Inc. | 3'-azido-2',3'-dideoxy-5-methylcytidine |
US4916122A (en) | 1987-01-28 | 1990-04-10 | University Of Georgia Research Foundation, Inc. | 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition |
US5077279A (en) | 1986-05-01 | 1991-12-31 | University Of Georgia Research Foundation, Inc. | 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition |
US5190926A (en) | 1987-01-28 | 1993-03-02 | University Of Georgia Research Foundation, Inc. | 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents |
NZ228645A (en) | 1988-04-11 | 1991-09-25 | Iaf Biochem Int | 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections |
US5041449A (en) | 1988-04-11 | 1991-08-20 | Iaf Biochem International, Inc. | 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections |
US5047407A (en) | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
DD293498A5 (de) | 1989-07-20 | 1991-09-05 | Zi Fuer Molekularbiologie Der Adw,De | Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier |
US5204466A (en) | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
DE4224737A1 (de) * | 1992-07-27 | 1994-02-03 | Herbert Prof Dr Schott | Neue Cytosinnucleosidanaloga, Verfahren zu ihrer Herstellung und ihre Verwendung |
JPH09504785A (ja) * | 1993-09-10 | 1997-05-13 | エモリー、ユニバーシティー | 抗b型肝炎ウイルス活性を有するヌクレオシド |
FR2709754B1 (fr) | 1993-09-10 | 1995-12-01 | Centre Nat Rech Scient | Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale. |
DE4418690A1 (de) | 1994-05-28 | 1996-01-11 | Boehringer Mannheim Gmbh | Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel |
US5559101A (en) | 1994-10-24 | 1996-09-24 | Genencor International, Inc. | L-ribofuranosyl nucleosides |
US5703058A (en) | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
AU722214B2 (en) | 1995-06-07 | 2000-07-27 | Centre National De La Recherche Scientifique (Cnrs) | Nucleosides with anti-hepatitis B virus activity |
ATE459361T1 (de) | 1995-09-07 | 2010-03-15 | Univ Georgia | Therapeutische azidverbindungen |
CZ120699A3 (cs) | 1996-10-16 | 1999-09-15 | Icn Pharmaceuticals, Inc. | Monocyklická L-nukleosidová analoga a jejich využití |
-
1999
- 1999-11-05 JP JP2000579613A patent/JP2002528554A/ja not_active Withdrawn
- 1999-11-05 IL IL14298399A patent/IL142983A0/xx active IP Right Grant
- 1999-11-05 CA CA002348470A patent/CA2348470C/en not_active Expired - Fee Related
- 1999-11-05 WO PCT/US1999/026157 patent/WO2000026225A2/en active IP Right Grant
- 1999-11-05 DE DE69929460T patent/DE69929460D1/de not_active Expired - Lifetime
- 1999-11-05 KR KR1020017005679A patent/KR100618028B1/ko not_active IP Right Cessation
- 1999-11-05 BR BR9915555-9A patent/BR9915555A/pt not_active IP Right Cessation
- 1999-11-05 US US09/435,261 patent/US6458773B1/en not_active Expired - Lifetime
- 1999-11-05 AU AU16085/00A patent/AU774720B2/en not_active Ceased
- 1999-11-05 EP EP99958793A patent/EP1124839B1/en not_active Expired - Lifetime
- 1999-11-05 CN CN998141895A patent/CN1216893C/zh not_active Expired - Fee Related
- 1999-11-05 MX MXPA01004504A patent/MXPA01004504A/es not_active IP Right Cessation
- 1999-11-05 AT AT99958793T patent/ATE315574T1/de not_active IP Right Cessation
-
2001
- 2001-05-04 IL IL142983A patent/IL142983A/en not_active IP Right Cessation
- 2001-09-27 HK HK01106816A patent/HK1036069A1/xx not_active IP Right Cessation
-
2011
- 2011-06-22 JP JP2011138647A patent/JP2011246469A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IL142983A (en) | 2006-07-05 |
JP2011246469A (ja) | 2011-12-08 |
KR20020013474A (ko) | 2002-02-20 |
CA2348470C (en) | 2007-06-05 |
MXPA01004504A (es) | 2005-04-19 |
WO2000026225A2 (en) | 2000-05-11 |
CA2348470A1 (en) | 2000-05-11 |
AU1608500A (en) | 2000-05-22 |
IL142983A0 (en) | 2002-04-21 |
ATE315574T1 (de) | 2006-02-15 |
BR9915555A (pt) | 2002-01-15 |
US6458773B1 (en) | 2002-10-01 |
JP2002528554A (ja) | 2002-09-03 |
EP1124839A2 (en) | 2001-08-22 |
EP1124839B1 (en) | 2006-01-11 |
AU774720B2 (en) | 2004-07-08 |
DE69929460D1 (de) | 2006-04-06 |
CN1329618A (zh) | 2002-01-02 |
WO2000026225A3 (en) | 2000-10-05 |
KR100618028B1 (ko) | 2006-08-30 |
CN1216893C (zh) | 2005-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1036069A1 (en) | Nucleosides with anti-hepatitis b virus activity | |
ATE313550T1 (de) | Beta-l-2'-deoxynukleoside für die behandlung von hepatitis b virus | |
CA2268703A1 (en) | Enantiomerically pure .beta.-d-dioxolane nucleosides with selective anti-hepatitis b virus activity | |
NZ330137A (en) | L-nucleoside and L-nucleotide derivatives and their use in treating a human infected with HBV or EBV | |
IL173586A0 (en) | Use of nucleoside analogues and doxorubicin in medicaments for treating leukemia | |
CA2215190A1 (en) | Aryl-ester phosphoramidate derivatives of nucleosides | |
CA2287370A1 (en) | Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides | |
BR9915037A (pt) | Nucleosìdeos ß-l-2'-deoxi para o tratamento deinfecção de hiv | |
ES2105923A1 (es) | Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv). | |
Long et al. | Synthesis and antitumor antiviral activities of 1-. beta.-D-arabinofuranosylpyrimidine 3', 5'-cyclic phosphates | |
Lu et al. | Effects of 5-fluorouridine on modified nucleosides in mouse liver transfer RNA | |
RU2001115094A (ru) | Нуклеозиды, обладающие активностью против вируса гепатита в | |
CA2538205A1 (en) | Nucleosides with anti-hepatitis b virus activity | |
RU96117323A (ru) | L-нуклеозиды для лечения заболеваний, вызванных вирусом гепатита b и вирусом эпштейна - барра | |
RU2001106651A (ru) | Бета-l-2 - дезокси-нуклеотиды для лечения гепатита в | |
JPS6426594A (en) | Nucleotides and antitumor agent | |
MX9603029A (es) | Nucleosidos-l para el tratamiento del virus-b de hepatitis y el virus de epstein-barr. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20131105 |